January 10, 2023
The Office of the Vice President for Ethics and Compliance has announced recipients of the 2023 Martin Luther King Jr. Dreamer Award. The Dreamer Award has been presented annually since 2004 to individuals or organizations within the Purdue University community whose contributions embody Martin Luther King Jr.’s vision of service to others and further the university’s commitment to diversity. The 2023 recipients are: Jean Chmielewski, interim dean and Alice Watson Kramer Distinguished Professor, College of Science, Purdue West Lafayette. Farah A. Combs, senior lecturer in Arabic and honors program director, Purdue Fort Wayne. Zenephia Evans, associate dean of students, education and advocacy, Office of the Dean of Students, Purdue West Lafayette. Shontrai D. Irving, clinical associate professor of business law, College of Business, Purdue Northwest.
January 10, 2023
Ophthalmologists, optometrists and their patients will benefit from new, high-tech tools to detect glaucoma at its earliest stages thanks to a startup that will commercialize smart contact lenses developed at Purdue University. According to the university, BVS Sight Inc. is the first company created through a partnership between Boomerang Ventures Studio, Purdue Foundry and the Purdue Research Foundation Office of Technology Commercialization. The partnership develops Purdue-related health care startups and health care-related intellectual property yet to reach the market.
New high-tech startup developing smart contact lenses for glaucoma diagnosis and management
January 9, 2023
Mohit Verma’s research team at Purdue University has developed innovative paper-based, rapid-result tests for bovine respiratory disease and COVID-19. Now the researchers are adapting their technology for produce safety risk assessment.
Innovative risk-assessment tool for produce industry continues advancing
January 9, 2023
Chi Hwan Lee, the Leslie A. Geddes Associate Professor of Biomedical Engineering in Purdue’s Weldon School of Biomedical Engineering, led a research team that developed new ocular technology to continuously monitor intraocular pressure (IOP) in a person’s eye.
New high-tech startup developing smart contact lenses for glaucoma diagnosis and management
December 22, 2022
Interstates across the country boast an innovative concrete technology that promises to save American travelers time and money. This “smart concrete” can communicate with engineers about its strength, weakness and need for repair – making road repair more efficient and preventing unnecessary shutdowns. Developed at Purdue University, the innovation is earning attention and has now been named one of the Next Big Things in Tech by Fast Company magazine.
Purdue University Invention Named A Next Big Thing In Tech By Fast Company Magazine
December 20, 2022
Purdue University on Tuesday announced several changes to its leadership team as President-elect Mung Chiang prepares to begin his tenure next month. Among them is Patrick Wolfe, who will become the university’s next provost and executive vice president for academic affairs and diversity, as well as Karen Plaut, who has been promoted to executive vice president for research.
December 16, 2022
A drug developed by a Purdue University researcher to help doctors identify cancerous tumors during lung surgery has been approved for use by the Food and Drug Administration. The approval from the FDA was announced Friday afternoon. The drug, developed by PU researcher Phil Low, is called Cytalux.
Lung cancer drug developed by Purdue researcher approved by FDA
December 16, 2022
The importance of removing all the malignant tissue, the difficulty in distinguishing cancerous tissue from healthy tissue and the widespread nature of this type of lung cancer make the use of Cytalux in lung cancer surgery a welcome development. Low, a chemist by trade, attacks these issues using his expertise in chemical reactions. Cytalux exploits the unique chemistry of cancer cells to light up the tumors. Cancer cells divide rapidly, much faster than normal cells. To do this, they need folate, a type of B vitamin — and lots of it. The genius of Cytalux is that, after being administered intravenously to a patient before surgery, it tags that folate compound with a fluorescent dye. The cancer cells grab for the folate but end up flagged with the fluorescent dye, too. During surgery, these cells then fluoresce under near-infrared light.
December 13, 2022
Two Purdue University engineering faculty members, one with a joint appointment in the College of Veterinary Medicine, have been named fellows of the National Academy of Inventors (NAI), the organization announced on Thursday (Dec. 8). J. Paul Robinson, Distinguished Professor of Cytometry in the veterinary college’s Department of Basic Medical Sciences and a professor in the Weldon School of Biomedical Engineering, and Amy R. Reibman, the Elmore Professor of Electrical and Computer Engineering, will be inducted at the Fellows Induction Ceremony during the 12th annual meeting of the NAI on June 27, 2023, in Washington, D.C. Their selection brings the number of current Purdue faculty NAI fellows to 18.
National Academy of Inventors names two Purdue faculty as 2022 fellows
December 13, 2022
Ball assumes the Executive Director position after serving as the Acting Executive Director since January 2022. Prior to that, she was Director of Public Relations and Science, also at GFF, and has been with the foundation since 2013. During her tenure, she has deepened and broadened GFF’s research program, has led the Foundation in increasing its public relations messaging reach, and has worked to build the Foundation’s relationships across academia, nutrition science organizations, and the food industry.
Grain Foods Foundation Announces Promotion of Erin E. Ball as the Foundation’s Executive Director
